CSF-1 drops demonstrate efficacy, safety in clinical studies for treatment of presbyopia

Article
Conferences|AAO

Elad Kedar, CEO of Orasis Pharmaceuticals, provides a company update at OIS@AAO 2018 in Chicago.


Elad Kedar, CEO of Orasis Pharmaceuticals, provides a company update at OIS@AAO 2018 in Chicago.

Recent Videos
Related Content
Jane C. Edmond, MD, starts term as 2024 president of AAO

Jane C. Edmond, MD, starts term as 2024 president of AAO

Article
Comparing micro-bypass implant + phaco vs phaco in POAG

Comparing micro-bypass implant + phaco vs phaco in POAG

Podcast
AAO 2023: Luminopia, first FDA-approved digital therapeutic for amblyopia

AAO 2023: Luminopia, first FDA-approved digital therapeutic for amblyopia

Article
Integrating AI to manage DR in a primary care setting

Integrating AI to manage DR in a primary care setting

Podcast
AAO 2023: GALE data at one year

AAO 2023: GALE data at one year

Article
AAO 2023: CoFi company updates and partnership with CareCredit

AAO 2023: CoFi company updates and partnership with CareCredit

Article
© 2024 MJH Life Sciences

All rights reserved.